TrialCritical care medicine2012

Angiotensin-converting enzyme inhibition or mineralocorticoid receptor blockade do not affect prevalence of atrial fibrillation in patients undergoing cardiac surgery.

Mias Pretorius et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.